Skip to main content
. 2018 Mar 7;8(1):1–11. doi: 10.1556/1886.2018.00002

Supplementary material 5.

Resistance of isolated Pseudomonas aeruginosa as identified by VITEK-II.

Pseudomonas aeruginosa from Libyan patients at the Bundeswehr Hospitals of Hamburg and Westerstede (n=3)
Piperacilli n Ceftazidim e Cefepim e Aztreona m Imipene m Meropene m Amikaci n Gentamici n Tobramyci n Ciprofloxaci n Colisti n Cotrimoxazol e
R 3 3 2 1 2 2 2 2
I 2 1
S 1 3 3 1 1 1 3 3
Pseudomonas aeruginosa from the environment of Libyan patients at the Bundeswehr Hospital of Hamburg (n=2)
Piperacilli n Ceftazidim e Cefepim e Aztreona m Imipene m Meropene m Amikaci n Gentamici n Tobramyci n Ciprofloxaci n Colisti n Cotrimoxazol e
R
I 2
S 2 2 2 2 2 2 2 2 2 2 2
Pseudomonas aeruginosa from Syrian patients at the Bundeswehr Hospitals of Hamburg and Westerstede (n=1)
Piperacilli n Ceftazidim e Cefepim e Aztreona m Imipene m Meropene m Amikaci n Gentamici n Tobramyci n Ciprofloxaci n Colisti n Cotrimoxazol e
R 1
I 1
S 1 1 1 1 1 1 1 1 1 1